Stork Therapeutics
Stork Therapeutics is a startup headquartered in San Francisco, United States, founded in 2024. It has raised at least $1.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Stork Therapeutics has raised at least $1.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Stork Therapeutics sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in San Francisco
- 3Scan
- 3TA Halo
- Aarki
- Accord Software
- Aeolus Labs
- Aerobotics7
- Agriful Software
- Ai-Coustics
- Aidora
- Aikido Technologies
- Aimerce
Related
- Innovation profile of San Francisco
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Stork Therapeutics do?
Stork Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Stork Therapeutics raised?
At least $1.3m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Stork Therapeutics based?
Stork Therapeutics is headquartered in San Francisco, United States.
When was Stork Therapeutics founded?
Stork Therapeutics was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.